Ascent Group
WST icon

Ascent Group’s West Pharmaceutical WST Stock Holding History

Ascent Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$238K Buy
+642
New +$227K 0.01% 738
2026
Q1 		– Sell
-754
Closed -$208K – 802
2025
Q4 		$208K Buy
+754
New +$206K 0.01% 712

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Ascent Group's WST Position: Q3 2026 in Review

Ascent Group opened a new position in West Pharmaceutical (WST) in Q3 2026: 642 shares worth $238K. The stake represents 0.01% of the portfolio and ranks #738 among its holdings. This is a return to the name: Ascent Group previously reported a position in WST as recently as Q4 2025.

Ascent Group first reported a position in WST in Q4 2025 and has held it in 2 quarters since. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Ascent Group held 642 shares of West Pharmaceutical worth $238K as of Q3 2026.
  • West Pharmaceutical was a new Ascent Group position in Q3 2026.
  • West Pharmaceutical made up 0.01% of Ascent Group's portfolio in Q3 2026, its #738 holding.
  • Ascent Group first reported a position in West Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Ascent Group's 13F filing for Q3 2026, filed 30 Oct 2026.